Table 1_Impact of comorbid burden on global left cardiac function and prediction models for myocardial function damage: a cardiac magnetic resonance feature-tracking study.docx حسب XiaoFeng Qu (20718092)

"…</p>Results<p>After adjustment, the left atrial (LA) reservoir strain (p = 0.011) and conduit strain (p < 0.001) were significantly lower in patients with a comorbid burden ≥2. …"

Axon Degradation of Dorsal Root Ganglion Cells from Laser Ablation Damage in the Presence of Mdiv Inhibitor حسب Sophia Liu (722004)

"…Results showed that Mdivi-1 treatment significantly reduced cell body degradation, with treated neurons exhibiting a smaller percentage decrease in cell body area compared to untreated controls. …"

Supplementary Material for: Preliminary efficacy, tolerability, and safety analysis of Darolutamide for metastatic castration‑resistant prostate cancer: a single-center, open-label... حسب Yu J. (3610580)

"…The median time to PSA50 in the Darolutamide group was 1.5 months (95%CI 0.2619- 0.9545), significantly lower than that in the placebo group (3.0 months [95%CI 1.048- 3.818], p= 0.0259); The median time to PSA90 in the experimental group was 4 months (95%CI 0.3094- 1.437), 2 months shorter than that in the placebo group (6.0 months [95%CI 0.6961- 3.232]).With the median follow-up of 6 months, , the median decrease in serum PSA was -81.8% (range -60.4 to -99.9%) in the Darolutamide group and -69.4% (range -50.3 to -89.6%) in the placebo group. …"

Table 6_Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.doc حسب Shujun Tan (20011518)

"…</p>Conclusion<p>This study illustrates the global progress made in reducing neonatal encephalopathy from 1990 to 2021; however, significant disparities persist. …"

Table 1_Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.doc حسب Shujun Tan (20011518)

"…</p>Conclusion<p>This study illustrates the global progress made in reducing neonatal encephalopathy from 1990 to 2021; however, significant disparities persist. …"

Table 2_Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.doc حسب Shujun Tan (20011518)

"…</p>Conclusion<p>This study illustrates the global progress made in reducing neonatal encephalopathy from 1990 to 2021; however, significant disparities persist. …"

Table 8_Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.doc حسب Shujun Tan (20011518)

"…</p>Conclusion<p>This study illustrates the global progress made in reducing neonatal encephalopathy from 1990 to 2021; however, significant disparities persist. …"

Table 5_Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.doc حسب Shujun Tan (20011518)

"…</p>Conclusion<p>This study illustrates the global progress made in reducing neonatal encephalopathy from 1990 to 2021; however, significant disparities persist. …"

Table 7_Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.doc حسب Shujun Tan (20011518)

"…</p>Conclusion<p>This study illustrates the global progress made in reducing neonatal encephalopathy from 1990 to 2021; however, significant disparities persist. …"

Table 4_Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.doc حسب Shujun Tan (20011518)

"…</p>Conclusion<p>This study illustrates the global progress made in reducing neonatal encephalopathy from 1990 to 2021; however, significant disparities persist. …"

Table 3_Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.doc حسب Shujun Tan (20011518)

"…</p>Conclusion<p>This study illustrates the global progress made in reducing neonatal encephalopathy from 1990 to 2021; however, significant disparities persist. …"

Effect of regional nerve block on tourniquet-related injury in pediatric patients undergoing lower limb surgery: a randomized controlled study حسب Qin Xia (1758646)

"…Additionally, patients in the PNB group had a significantly shorter time to first ambulation and a shorter hospital length of stay.…"

[A] Histopathological images of pancreas, liver, kidney, and heart tissues from the studied rat groups, stained with H&E. حسب Mohamed Lotfy (18599184)

"…^# Indicates significant difference (P ≤ 0.05) between the untreated diabetic group and the control group. * Indicates a significant difference (P ≤ 0.05) between the C. lancifolius-treated or crocin-treated diabetic group and the untreated diabetic group. …"

Table 1_Longitudinal changes in vitamin D during twin pregnancy: association with maternal–neonatal outcomes.docx حسب Zhentong Dai (22629206)

"…No statistically significant evidence was found between rising VD levels from mid- to late pregnancy and reduced sPTB risk vs. persistent low gestational VD levels. …"

Table 1_Effects of vegetation restoration on soil fungi community structure and assembly process in a semiarid alpine mining region.docx حسب Yuanyuan Xue (6442661)

"…</p>Results<p>Artificial vegetation restoration significantly enhanced the α diversity of soil fungal communities while reducing β diversity. …"

Table 1_Ten days of supplementation with a standardized Boswellia serrata extract attenuates soreness and accelerates recovery after repeated bouts of downhill running in recreatio... حسب Dawna Salter (18498396)

"…Blood and urine samples collected at baseline, before, and after DHR were analyzed for inflammation-related biomarkers. VAS scores significantly increased while muscle strength decreased from baseline measures after DHR regardless of group assignment (main effect of time p < 0.001). …"

Supplementary file 1_Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells.jpeg حسب Donatella Treppiedi (10146335)

"…Moreover, SRPIN340 significantly decreased both transcript (-56.3 (38.6)%, p<0.01 vs control cells) and protein levels (-33.5 (3.4)%, p<0.05 vs control cells) of the pro-survival VEGF164a isoform. …"

Image 1_Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells.jpg حسب Donatella Treppiedi (10146335)

"…Moreover, SRPIN340 significantly decreased both transcript (-56.3 (38.6)%, p<0.01 vs control cells) and protein levels (-33.5 (3.4)%, p<0.05 vs control cells) of the pro-survival VEGF164a isoform. …"

Table 1_The association between lutein and zeaxanthin intake and multi-level biological aging.docx حسب Meiyi Tao (17040531)

"…</p>Conclusion<p>Combined LZ intake is associated with attenuated multi-level biological aging [OR (95% CI): 0.93 (0.88, 0.93), P = 0.016] and high LZ intake significantly reduce the risk of all-cause death (P < 0.001), with lutein driving systemic effects via telomere regulation and inflammation suppression. …"

Table 1_The effectiveness of exercise interventions in the improvement of sleep in older adult people: a meta-analysis.docx حسب Di Geng (1681915)

"…In terms of clinician-reported sleep parameters, exercise interventions resulted in increased total sleep time (WMD = 8.98, 95%CI: 1.19 to 16.78, p < 0.05) and sleep efficiency (WMD = 3.66, 95%CI: 2.46 to 4.85, p < 0.01), and reduced wake time after sleep onset (WMD = −11.85, 95%CI: −15.58 to −8.11, p < 0.01), but did not decrease sleep onset latency (WMD = −3.05, 95%CI: −6.23 to 0.13, p = 0.06) or the number of awakenings during sleep (WMD = −0.73, 95%CI: −1.98 to 0.52, p = 0.25).…"